Back to FHTX
UBS Group AG FHTX Position History
Foghorn Therapeutics Inc. • Healthcare
Quarters held
12
Latest value
$427K
Q3 2026
Peak value
$427K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $34K |
| Q3 2025 | $121K |
| Q3 2025 | $16K |
| Q4 2025 | $38K |
| Q4 2025 | $94K |
| Q4 2025 | $200 |
| Q1 2026 | $37K |
| Q1 2026 | $326K |
| Q2 2026 | $34K |
| Q2 2026 | $21K |
| Q3 2026 | $21K |
| Q3 2026 | $427K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $427K | 119.5K | — | — |
| Q3 2026 | $21K | 6.0K | — | — |
| Q2 2026 | $21K | 4.3K | — | — |
| Q2 2026 | $34K | 6.9K | — | — |
| Q1 2026 | $326K | 68.2K | — | — |
| Q1 2026 | $37K | 7.7K | — | — |
| Q4 2025 | $200 | 37 | — | — |
| Q4 2025 | $94K | 17.5K | — | — |
| Q4 2025 | $38K | 7.0K | — | — |
| Q3 2025 | $16K | 3.2K | — | — |
| Q3 2025 | $121K | 24.7K | — | — |
| Q3 2025 | $34K | 7.0K | — | — |
Other funds holding FHTX
$68.4M
$61.8M
$60.6M
$45.2M
$34.4M
$30.8M
$28.9M
$28.6M